Genus Future Growth
Future criteria checks 3/6
Genus is forecast to grow earnings and revenue by 21.5% and 5.1% per annum respectively. EPS is expected to grow by 22.1% per annum. Return on equity is forecast to be 11% in 3 years.
Key information
21.5%
Earnings growth rate
22.1%
EPS growth rate
Biotechs earnings growth | 30.9% |
Revenue growth rate | 5.1% |
Future return on equity | 11.0% |
Analyst coverage | Good |
Last updated | 06 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 748 | 57 | 58 | 82 | 5 |
6/30/2025 | 711 | 47 | 57 | 84 | 6 |
6/30/2024 | 674 | 30 | 20 | 48 | 6 |
12/31/2023 | 673 | 33 | 10 | 45 | N/A |
9/30/2023 | 681 | 33 | 13 | 48 | N/A |
6/30/2023 | 690 | 33 | 15 | 50 | N/A |
3/31/2023 | 676 | 34 | -1 | 42 | N/A |
12/31/2022 | 662 | 34 | -18 | 35 | N/A |
9/30/2022 | 628 | 38 | -25 | 34 | N/A |
6/30/2022 | 593 | 41 | -31 | 34 | N/A |
3/31/2022 | 582 | 39 | -20 | 39 | N/A |
12/31/2021 | 570 | 37 | -9 | 43 | N/A |
9/30/2021 | 572 | 42 | 13 | 55 | N/A |
6/30/2021 | 574 | 47 | 34 | 68 | N/A |
3/31/2021 | 570 | 45 | 42 | 70 | N/A |
12/31/2020 | 566 | 42 | 50 | 72 | N/A |
9/30/2020 | 559 | 39 | 40 | 66 | N/A |
6/30/2020 | 551 | 35 | 30 | 60 | N/A |
3/31/2020 | 536 | 37 | 25 | 55 | N/A |
12/31/2019 | 520 | 39 | 19 | 49 | N/A |
9/30/2019 | 504 | 23 | 12 | 41 | N/A |
6/30/2019 | 489 | 8 | 5 | 33 | N/A |
3/31/2019 | 480 | 1 | 6 | 35 | N/A |
12/31/2018 | 471 | -7 | 7 | 37 | N/A |
9/30/2018 | 470 | 18 | 14 | 40 | N/A |
6/30/2018 | 470 | 43 | 21 | 43 | N/A |
3/31/2018 | 473 | 55 | 23 | 42 | N/A |
12/31/2017 | 476 | 67 | 25 | 41 | N/A |
9/30/2017 | 467 | 50 | N/A | 38 | N/A |
6/30/2017 | 459 | 33 | N/A | 35 | N/A |
3/31/2017 | 441 | 40 | N/A | 34 | N/A |
12/31/2016 | 422 | 47 | N/A | 33 | N/A |
9/30/2016 | 405 | 48 | N/A | 31 | N/A |
6/30/2016 | 388 | 49 | N/A | 30 | N/A |
3/31/2016 | 388 | 40 | N/A | 25 | N/A |
12/31/2015 | 388 | 31 | N/A | 21 | N/A |
9/30/2015 | 393 | 35 | N/A | 28 | N/A |
6/30/2015 | 399 | 40 | N/A | 35 | N/A |
3/31/2015 | 394 | 36 | N/A | 38 | N/A |
12/31/2014 | 389 | 32 | N/A | 41 | N/A |
9/30/2014 | 381 | 30 | N/A | 37 | N/A |
6/30/2014 | 372 | 29 | N/A | 32 | N/A |
3/31/2014 | 366 | 27 | N/A | 33 | N/A |
12/31/2013 | 360 | 25 | N/A | 34 | N/A |
9/30/2013 | 353 | 24 | N/A | 29 | N/A |
6/30/2013 | 345 | 23 | N/A | 24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GBE's forecast earnings growth (21.5% per year) is above the savings rate (0.7%).
Earnings vs Market: GBE's earnings (21.5% per year) are forecast to grow faster than the German market (16% per year).
High Growth Earnings: GBE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GBE's revenue (5.1% per year) is forecast to grow slower than the German market (5.1% per year).
High Growth Revenue: GBE's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GBE's Return on Equity is forecast to be low in 3 years time (11%).